Teva Pharmaceutical Industries (TEVA) Free Cash Flow (QoQ) (2009 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Free Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 247.60% |
| Mar 31, 2026 | -120.47% |
| Dec 31, 2025 | 336.05% |
| Sep 30, 2025 | 77.86% |
| Jun 30, 2025 | 156.47% |
| Mar 31, 2025 | -152.02% |
| Dec 31, 2024 | -18.17% |
| Sep 30, 2024 | 8,983.33% |
| Jun 30, 2024 | 102.42% |
| Mar 31, 2024 | -123.29% |
| Dec 31, 2023 | 839.58% |
| Sep 30, 2023 | -170.24% |
| Jun 30, 2023 | 172.18% |
| Mar 31, 2023 | -134.18% |
| Dec 31, 2022 | 97.39% |
| Sep 30, 2022 | 10,625.00% |
| Jun 30, 2022 | 98.06% |
| Mar 31, 2022 | -167.99% |
| Dec 31, 2021 | -20.89% |
| Sep 30, 2021 | 264.76% |